Altering β-cell number through stable alteration of miR-21 and miR-34a expression

Islets

Volumn 6, Issue FEB, 2014, Pages

  Backe, Marie Balslev ^a   Novotny, Guy Wayne ^a   Christensen, Dan Ploug ^a   Grunnet, Lars Groth ^a,b   Mandrup Poulsen, Thomas ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Cytokines; Diabetes mellitus; Micro RNA; Proliferation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; LENTIVIRUS VECTOR; MICRORNA 21; MICRORNA 34A; NITRIC OXIDE; CYTOKINE; MICRORNA; MIRN21 MICRORNA, RAT; MIRN34 MICRORNA, RAT;

ADHERENT CELL; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INSULINOMA; NONHUMAN; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RAT; WILD TYPE; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM;

ANIMALS; APOPTOSIS; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INSULIN-SECRETING CELLS; MICRORNAS; NITRIC OXIDE; RATS; TRANSFECTION;

EID: 84901942076     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.27754     Document Type: Article

References (48)

1. Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 2008; 29:334-50; PMID:18048762; http://dx.doi.org/10.1210/er.2007- 0033
2. Donath MY, Størling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl) 2003; 81:455-70; PMID:12879149; http://dx.doi.org/10. 1007/s00109-003-0450-y
3. Giannoukakis N, Rudert WA, Trucco M, Robbins PD. Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J Biol Chem 2000; 275:36509-13; PMID:10967112; http://dx.doi.org/10.1074/jbc.M005943200
4. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 2001; 50:2219-24; PMID:11574401; http://dx.doi.org/10.2337/ diabetes.50.10.2219
5. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356:1517-26; PMID:17429083; http://dx.doi.org/10.1056/NEJMoa065213
6. Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, et al. Interleukin-1 antagonism in type one diabetes of recent onset: two multicentre, randomized, double-blind, placebo-controlled trials. Lancer 2013; 38:1905-15; http://dx.doi.org/10.1016/S0140-6736(13)60023-9
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045- 5
8. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92-105; PMID:18955434; http://dx.doi.org/10.1101/gr.082701.108
9. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 2007; 56:2938-45; PMID:17804764; http://dx.doi.org/10.2337/db07-0175
10. Tang X, Tang G, Ozcan S. Role of microRNAs in diabetes. Biochim Biophys Acta 2008; 1779:697-701; PMID:18655850; http://dx.doi.org/10.1016/j.bbagrm.2008. 06.010
11. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432:226-30; PMID:15538371; http://dx.doi.org/10.1038/nature03076
12. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A, Regazzi R. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008; 57:2728-36; PMID:18633110; http://dx.doi.org/10.2337/db07-1252
13. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, Regazzi R. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 2010; 59:978-86; PMID:20086228; http://dx.doi.org/10.2337/db09-0881
14. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11:141-7; PMID:19946272; http://dx.doi.org/10.1038/ni.1828
15. Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F, Shi W, Chen YH. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A 2011; 108:12030-5; PMID:21730150; http://dx.doi.org/10.1073/pnas.1101450108
16. Zhou R, Hu G, Liu J, Gong AY, Drescher KM, Chen XM. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog 2009; 5:e1000681; PMID:19997496; http://dx.doi.org/10.1371/journal.ppat.1000681
17. Ma X, Buscaglia LEB, Barker JR, Li Y. MicroRNAs in NF-κ B signaling. J Mol Cell Biol 2011; 0:1-8
18. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009; 4:e6816; PMID:19714243; http://dx.doi.org/10.1371/journal.pone.0006816
19. Kasar S, Salerno E, Yuan Y, Underbayev C, Vollenweider D, Laurindo MF, Fernandes H, Bonci D, Addario A, Mazzella F, et al. Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia. Genes Immun 2012; 13:109-19; PMID:21881595; http://dx.doi.org/10.1038/gene.2011.58
20. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65:6029-33; PMID:16024602; http://dx.doi.org/10.1158/0008-5472.CAN-05-0137
21. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009; 13:39-53; PMID:19175699; http://dx.doi.org/10.1111/j.1582-4934.2008. 00556.x
22. Gaur AB, Holbeck SL, Colburn NH, Israel MA. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol 2011; 13:580-90; PMID:21636706; http://dx.doi.org/10.1093/neuonc/nor033
23. Hu H, Li Y, Gu J, Zhu X, Dong D, Yao J, Lin C, Fei J. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leuk Lymphoma 2010; 51:694-701; PMID:20141427; http://dx.doi.org/10.3109/10428191003596835
24. Park JK, Lee EJ, Esau C, Schmittgen TD. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 2009; 38:e190-9; PMID:19730150; http://dx.doi.org/10.1097/MPA.0b013e3181ba82e1
25. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647-58; PMID:17681183; http://dx.doi.org/10.1053/j.gastro.2007.05.022
26. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282:14328-36; PMID:17363372; http://dx.doi.org/10.1074/jbc.M611393200
27. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009; 37:918-25; PMID:19614619; http://dx.doi.org/10.1042/BST0370918
28. Lu TX, Lim EJ, Itskovich S, Besse JA, Plassard AJ, Mingler MK, Rothenberg JA, Fulkerson PC, Aronow BJ, Rothenberg ME. Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth. PLoS One 2013; 8:e59397; PMID:23533623; http://dx.doi.org/10.1371/journal.pone.0059397
29. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009; 15:3998-4008; PMID:19509158; http://dx.doi.org/10.1158/1078-0432.CCR-08-3053
30. Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68:8164-72; PMID:18829576; http://dx.doi.org/10.1158/0008-5472.CAN-08-1305
31. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005; 33:1290-7; PMID:15741182; http://dx.doi.org/10.1093/ nar/gki200
32. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39:493-506; PMID:20797623; http://dx.doi.org/10.1016/j.molcel.2010.07.023
33. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11:141-7; PMID:19946272; http://dx.doi.org/10.1038/ni.1828
34. Eto K, Goto S, Nakashima W, Ura Y, Abe SI. Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ 2012; 19:573-81; PMID:21959934; http://dx.doi.org/10.1038/cdd.2011. 126
35. Novotny GW, Sonne SB, Nielsen JE, Jonstrup SP, Hansen MA, Skakkebaek NE, Rajpert-De Meyts E, Kjems J, Leffers H. Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ 2007; 14:879-82; PMID:17218954; http://dx.doi.org/ 10.1038/sj.cdd.4402090
36. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26:731-43; PMID:17540598; http://dx.doi.org/10.1016/j.molcel.2007.05.017
37. Guo Y, Li S, Qu J, Wang S, Dang Y, Fan J, Yu S, Zhang J. MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells. Mol Cell Biochem 2011; 354:275-82; PMID:21553024; http://dx.doi.org/10.1007/s11010-011-0827-0
38. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26:745-52; PMID:17540599; http://dx.doi.org/10.1016/j.molcel.2007.05. 010
39. Li WB, Ma MW, Dong LJ, Wang F, Chen LX, Li XR. MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol Ther 2011; 12:477-83; PMID:21743299; http://dx.doi.org/10.4161/cbt.12.6.16300
40. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26:5017-22; PMID:17297439; http://dx.doi.org/10.1038/sj.onc.1210293
41. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 2008; 105:13421-6; PMID:18755897; http://dx.doi.org/10.1073/pnas.0801613105
42. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434:113-8; PMID:15744310; http://dx.doi.org/10.1038/ nature03354
43. Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-Méneur C, Permutt MA, Imai S. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab 2005; 2:105-17; PMID:16098828; http://dx.doi.org/10.1016/j.cmet.2005. 07.001
44. Biason-Lauber A, Böni-Schnetzler M, Hubbard BP, Bouzakri K, Brunner A, Cavelti-Weder C, Keller C, Meyer-Böni M, Meier DT, Brorsson C, et al. Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab 2013; 17:448-55; PMID:23473037; http://dx.doi.org/10.1016/j.cmet.2013.02.001
45. Parnaud G, Bosco D, Berney T, Pattou F, Kerr-Conte J, Donath MY, Bruun C, Mandrup-Poulsen T, Billestrup N, Halban PA. Proliferation of sorted human and rat beta cells. Diabetologia 2008; 51:91-100; PMID:17994216; http://dx.doi.org/10.1007/s00125-007-0855-1
46. Russ HA, Bar Y, Ravassard P, Efrat S. In vitro proliferation of cells derived from adult human betacells revealed by cell-lineage tracing. Diabetes 2008; 57:1575-83; PMID:18316362; http://dx.doi.org/10.2337/db07-1283
47. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-8; PMID:18546601; http://dx.doi.org/10. 1038/nprot.2008.73
48. Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P, Christensen ST. PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. Curr Biol 2005; 15:1861-6; PMID:16243034; http://dx.doi.org/10.1016/j.cub.2005.09.012